Sorting Through the Relations Among Metabolic Syndrome, Insulin Resistance, and Endothelial Dysfunction

American Journal of Cardiology

Volumn 101, Issue 1, 2008, Pages 127-128

  Kelly, Aaron S ^a,b   Steinberger, Julia ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b St Paul Heart Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; INSULIN; NITRIC OXIDE;

ARTERY WALL; ATHEROSCLEROSIS; BLOOD FLOW; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HOMEOSTASIS; HUMAN; HYPEREMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR;

BLOOD FLOW VELOCITY; BRACHIAL ARTERY; HUMANS; HYPEREMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; VASODILATION;

EID: 37349083866     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.08.028     Document Type: Editorial

References (8)

1. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
2. Meigs J.B., Rutter M.K., Sullivan L.M., Fox C.S., D'Agostino Sr. R.B., and Wilson P.W. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 30 (2007) 1219-1225
3. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
4. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
5. Hamburg N.M., Larson M.G., Vita J.A., Vasan R.S., Keyes M.J., Widlansky M.E., Fox C.S., Mitchell G.F., Levy D., Meigs J.B., and Benjamin E.J. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 101 (2008) 82-88
6. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
7. Gokce N., Keaney Jr. J.F., Hunter L.M., Watkins M.T., Nedeljkovic Z.S., Menzoian J.O., and Vita J.A. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41 (2003) 1769-1775
8. Yoshida T., Kawano H., Miyamoto S., Motoyama T., Fukushima H., Hirai N., and Ogawa H. Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease. Intern Med 45 (2006) 575-579